IGC Pharma enters 5-year employment agreement with PFO Claudia Grimaldi; $200k base salary

IGC Pharma, Inc.

Five-year initial term with auto-renew; $200,000 annual base salary, subject to annual Board review.
Eligible for annual bonus and equity grants under 2018 Omnibus Incentive Plan.
Severance: if terminated without cause or for good reason, receives either base pay for remainder of term or 1.5x avg total compensation of prior 2 years; plus health and D&O coverage.
In change-of-control scenario within 12 months, severance multiplier rises to 2.99x and all unvested equity vests immediately.
Executive receives auto allowance ($95/month personal use), 20 days vacation, 8 days sick leave, and indemnification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.